Michael J Birrer

Michael J Birrer

UNVERIFIED PROFILE

Are you Michael J Birrer?   Register this Author

Register author
Michael J Birrer

Michael J Birrer

Publications by authors named "Michael J Birrer"

Are you Michael J Birrer?   Register this Author

100Publications

2763Reads

15Profile Views

Ovarian Cancer Maintenance: Practice-Changing Data Calls for Changing Practice.

Oncologist 2019 May 20;24(5):576-579. Epub 2019 Mar 20.

University of Cincinnati Cancer Institute, University of Cincinnati Medical Center, Cincinnati, Ohio, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0020DOI Listing
May 2019

Real-Time Single-Walled Carbon Nanotube-Based Fluorescence Imaging Improves Survival after Debulking Surgery in an Ovarian Cancer Model.

ACS Nano 2019 May 25;13(5):5356-5365. Epub 2019 Apr 25.

Center for Cancer Research, The Gillette Center for Gynecologic Oncology , Massachusetts General Hospital, Harvard Medical School , Boston , Massachusetts 02114 , United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsnano.8b09829DOI Listing
May 2019

Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian Cancer.

Cancers (Basel) 2019 May 14;11(5). Epub 2019 May 14.

O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35233, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11050668DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562901PMC
May 2019

Is Targeting the Folate Receptor in Ovarian Cancer Coming of Age?

Oncologist 2019 Apr 11;24(4):425-429. Epub 2019 Jan 11.

Stephenson Oklahoma Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/lookup/doi/10.1634/th
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2018-0459DOI Listing
April 2019

Methods for Systematic Identification of Membrane Proteins for Specific Capture of Cancer-Derived Extracellular Vesicles.

Cell Rep 2019 Apr;27(1):255-268.e6

Department of Neurology, Massachusetts General Hospital, Charlestown, MA 02129, USA; Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA; Department of Radiology, Massachusetts General Hospital, Boston, MA 02114, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22111247193031
Publisher Site
http://dx.doi.org/10.1016/j.celrep.2019.03.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528836PMC
April 2019

Variation in resource utilization associated with the surgical management of ovarian cancer.

Gynecol Oncol 2019 03 19;152(3):587-593. Epub 2018 Dec 19.

Massachusetts General Physicians Organization, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258183151
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2018.12.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420848PMC
March 2019

Antibody-Drug Conjugate-Based Therapeutics: State of the Science.

J Natl Cancer Inst 2019 Mar 11. Epub 2019 Mar 11.

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL (MJB,IB); Stephenson Oklahoma Cancer Center at the Univeristy of Oklahoma Health Sciences Center, Oklahoma City, OK/ Sarah Cannon Research Institute, Nashville, TN (KNM); ImmunoGen Inc., Waltham, MA (RCB).

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/advance-article/doi/10.1093/jn
Publisher Site
http://dx.doi.org/10.1093/jnci/djz035DOI Listing
March 2019

ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer Progression.

Cancers (Basel) 2018 Nov 22;10(12). Epub 2018 Nov 22.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers10120464DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316352PMC
November 2018

FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer.

Future Oncol 2018 Jul 9;14(17):1669-1678. Epub 2018 Feb 9.

Division of Hematology-Oncology, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL 35294, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0646DOI Listing
July 2018

Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance.

J Clin Invest 2018 02 18;128(2):589-606. Epub 2017 Dec 18.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI95200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785271PMC
February 2018

A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer.

Future Oncol 2018 Jan 3;14(2):123-136. Epub 2017 Nov 3.

Gillette Center for Gynecologic Oncology, Massachusetts General Hospital, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0379DOI Listing
January 2018

Differential Effects of EGFL6 on Tumor versus Wound Angiogenesis.

Cell Rep 2017 Dec;21(10):2785-2795

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2017.11.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749980PMC
December 2017

Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses.

J Natl Cancer Inst 2017 11;109(11)

Genentech Inc., South San Francisco, CA; F Hoffmann-La Roche Ltd, Basel, Switzerland; NRG Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, NY; University of Oklahoma, Oklahoma City, OK; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, PA; Center for Cancer Research, Gillette Center for Gynecologic Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; HistoGeneX NV, Antwerp, Belgium; Division of Physiopharmacology, University of Antwerp, Antwerp, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djx066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440032PMC
November 2017

Integrated genomic analysis of clear cell ovarian cancers identified PRKCI as a potential therapeutic target.

Oncotarget 2017 Nov 4;8(57):96482-96495. Epub 2017 Aug 4.

Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.19946DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722499PMC
November 2017

CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.

PLoS One 2016 2;11(6):e0156595. Epub 2016 Jun 2.

Pediatric Surgical Research Laboratories, Massachusetts General Hospital, Department of Surgery, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0156595PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890777PMC
July 2017

Early tumor detection afforded by in vivo imaging of near-infrared II fluorescence.

Biomaterials 2017 Jul 25;134:202-215. Epub 2017 Apr 25.

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Building 76, Cambridge, MA 02139, United States; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02115, United States; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biomaterials.2017.04.046DOI Listing
July 2017

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.

Authors:
Catherine M Phelan Karoline B Kuchenbaecker Jonathan P Tyrer Siddhartha P Kar Kate Lawrenson Stacey J Winham Joe Dennis Ailith Pirie Marjorie J Riggan Ganna Chornokur Madalene A Earp Paulo C Lyra Janet M Lee Simon Coetzee Jonathan Beesley Lesley McGuffog Penny Soucy Ed Dicks Andrew Lee Daniel Barrowdale Julie Lecarpentier Goska Leslie Cora M Aalfs Katja K H Aben Marcia Adams Julian Adlard Irene L Andrulis Hoda Anton-Culver Natalia Antonenkova Gerasimos Aravantinos Norbert Arnold Banu K Arun Brita Arver Jacopo Azzollini Judith Balmaña Susana N Banerjee Laure Barjhoux Rosa B Barkardottir Yukie Bean Matthias W Beckmann Alicia Beeghly-Fadiel Javier Benitez Marina Bermisheva Marcus Q Bernardini Michael J Birrer Line Bjorge Amanda Black Kenneth Blankstein Marinus J Blok Clara Bodelon Natalia Bogdanova Anders Bojesen Bernardo Bonanni Åke Borg Angela R Bradbury James D Brenton Carole Brewer Louise Brinton Per Broberg Angela Brooks-Wilson Fiona Bruinsma Joan Brunet Bruno Buecher Ralf Butzow Saundra S Buys Trinidad Caldes Maria A Caligo Ian Campbell Rikki Cannioto Michael E Carney Terence Cescon Salina B Chan Jenny Chang-Claude Stephen Chanock Xiao Qing Chen Yoke-Eng Chiew Jocelyne Chiquette Wendy K Chung Kathleen B M Claes Thomas Conner Linda S Cook Jackie Cook Daniel W Cramer Julie M Cunningham Aimee A D'Aloisio Mary B Daly Francesca Damiola Sakaeva Dina Damirovna Agnieszka Dansonka-Mieszkowska Fanny Dao Rosemarie Davidson Anna DeFazio Capucine Delnatte Kimberly F Doheny Orland Diez Yuan Chun Ding Jennifer Anne Doherty Susan M Domchek Cecilia M Dorfling Thilo Dörk Laure Dossus Mercedes Duran Matthias Dürst Bernd Dworniczak Diana Eccles Todd Edwards Ros Eeles Ursula Eilber Bent Ejlertsen Arif B Ekici Steve Ellis Mingajeva Elvira Kevin H Eng Christoph Engel D Gareth Evans Peter A Fasching Sarah Ferguson Sandra Fert Ferrer James M Flanagan Zachary C Fogarty Renée T Fortner Florentia Fostira William D Foulkes George Fountzilas Brooke L Fridley Tara M Friebel Eitan Friedman Debra Frost Patricia A Ganz Judy Garber María J García Vanesa Garcia-Barberan Andrea Gehrig Aleksandra Gentry-Maharaj Anne-Marie Gerdes Graham G Giles Rosalind Glasspool Gord Glendon Andrew K Godwin David E Goldgar Teodora Goranova Martin Gore Mark H Greene Jacek Gronwald Stephen Gruber Eric Hahnen Christopher A Haiman Niclas Håkansson Ute Hamann Thomas V O Hansen Patricia A Harrington Holly R Harris Jan Hauke Alexander Hein Alex Henderson Michelle A T Hildebrandt Peter Hillemanns Shirley Hodgson Claus K Høgdall Estrid Høgdall Frans B L Hogervorst Helene Holland Maartje J Hooning Karen Hosking Ruea-Yea Huang Peter J Hulick Jillian Hung David J Hunter David G Huntsman Tomasz Huzarski Evgeny N Imyanitov Claudine Isaacs Edwin S Iversen Louise Izatt Angel Izquierdo Anna Jakubowska Paul James Ramunas Janavicius Mats Jernetz Allan Jensen Uffe Birk Jensen Esther M John Sharon Johnatty Michael E Jones Päivi Kannisto Beth Y Karlan Anthony Karnezis Karin Kast Catherine J Kennedy Elza Khusnutdinova Lambertus A Kiemeney Johanna I Kiiski Sung-Won Kim Susanne K Kjaer Martin Köbel Reidun K Kopperud Torben A Kruse Jolanta Kupryjanczyk Ava Kwong Yael Laitman Diether Lambrechts Nerea Larrañaga Melissa C Larson Conxi Lazaro Nhu D Le Loic Le Marchand Jong Won Lee Shashikant B Lele Arto Leminen Dominique Leroux Jenny Lester Fabienne Lesueur Douglas A Levine Dong Liang Clemens Liebrich Jenna Lilyquist Loren Lipworth Jolanta Lissowska Karen H Lu Jan Lubinński Craig Luccarini Lene Lundvall Phuong L Mai Gustavo Mendoza-Fandiño Siranoush Manoukian Leon F A G Massuger Taymaa May Sylvie Mazoyer Jessica N McAlpine Valerie McGuire John R McLaughlin Iain McNeish Hanne Meijers-Heijboer Alfons Meindl Usha Menon Arjen R Mensenkamp Melissa A Merritt Roger L Milne Gillian Mitchell Francesmary Modugno Joanna Moes-Sosnowska Melissa Moffitt Marco Montagna Kirsten B Moysich Anna Marie Mulligan Jacob Musinsky Katherine L Nathanson Lotte Nedergaard Roberta B Ness Susan L Neuhausen Heli Nevanlinna Dieter Niederacher Robert L Nussbaum Kunle Odunsi Edith Olah Olufunmilayo I Olopade Håkan Olsson Curtis Olswold David M O'Malley Kai-Ren Ong N Charlotte Onland-Moret Nicholas Orr Sandra Orsulic Ana Osorio Domenico Palli Laura Papi Tjoung-Won Park-Simon James Paul Celeste L Pearce Inge Søkilde Pedersen Petra H M Peeters Bernard Peissel Ana Peixoto Tanja Pejovic Liisa M Pelttari Jennifer B Permuth Paolo Peterlongo Lidia Pezzani Georg Pfeiler Kelly-Anne Phillips Marion Piedmonte Malcolm C Pike Anna M Piskorz Samantha R Poblete Timea Pocza Elizabeth M Poole Bruce Poppe Mary E Porteous Fabienne Prieur Darya Prokofyeva Elizabeth Pugh Miquel Angel Pujana Pascal Pujol Paolo Radice Johanna Rantala Christine Rappaport-Fuerhauser Gad Rennert Kerstin Rhiem Patricia Rice Andrea Richardson Mark Robson Gustavo C Rodriguez Cristina Rodríguez-Antona Jane Romm Matti A Rookus Mary Anne Rossing Joseph H Rothstein Anja Rudolph Ingo B Runnebaum Helga B Salvesen Dale P Sandler Minouk J Schoemaker Leigha Senter V Wendy Setiawan Gianluca Severi Priyanka Sharma Tameka Shelford Nadeem Siddiqui Lucy E Side Weiva Sieh Christian F Singer Hagay Sobol Honglin Song Melissa C Southey Amanda B Spurdle Zsofia Stadler Doris Steinemann Dominique Stoppa-Lyonnet Lara E Sucheston-Campbell Grzegorz Sukiennicki Rebecca Sutphen Christian Sutter Anthony J Swerdlow Csilla I Szabo Lukasz Szafron Yen Y Tan Jack A Taylor Muy-Kheng Tea Manuel R Teixeira Soo-Hwang Teo Kathryn L Terry Pamela J Thompson Liv Cecilie Vestrheim Thomsen Darcy L Thull Laima Tihomirova Anna V Tinker Marc Tischkowitz Silvia Tognazzo Amanda Ewart Toland Alicia Tone Britton Trabert Ruth C Travis Antonia Trichopoulou Nadine Tung Shelley S Tworoger Anne M van Altena David Van Den Berg Annemarie H van der Hout Rob B van der Luijt Mattias Van Heetvelde Els Van Nieuwenhuysen Elizabeth J van Rensburg Adriaan Vanderstichele Raymonda Varon-Mateeva Ana Vega Digna Velez Edwards Ignace Vergote Robert A Vierkant Joseph Vijai Athanassios Vratimos Lisa Walker Christine Walsh Dorothea Wand Shan Wang-Gohrke Barbara Wappenschmidt Penelope M Webb Clarice R Weinberg Jeffrey N Weitzel Nicolas Wentzensen Alice S Whittemore Juul T Wijnen Lynne R Wilkens Alicja Wolk Michelle Woo Xifeng Wu Anna H Wu Hannah Yang Drakoulis Yannoukakos Argyrios Ziogas Kristin K Zorn Steven A Narod Douglas F Easton Christopher I Amos Joellen M Schildkraut Susan J Ramus Laura Ottini Marc T Goodman Sue K Park Linda E Kelemen Harvey A Risch Mads Thomassen Kenneth Offit Jacques Simard Rita Katharina Schmutzler Dennis Hazelett Alvaro N Monteiro Fergus J Couch Andrew Berchuck Georgia Chenevix-Trench Ellen L Goode Thomas A Sellers Simon A Gayther Antonis C Antoniou Paul D P Pharoah

Nat Genet 2017 May 27;49(5):680-691. Epub 2017 Mar 27.

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.3826DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612337PMC
May 2017

Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study.

J Clin Oncol 2017 Apr 28;35(10):1112-1118. Epub 2016 Dec 28.

Kathleen N. Moore, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Lainie P. Martin, Fox Chase Cancer Center, Philadelphia, PA; David M. O'Malley, Ohio State University James Cancer Center, Columbus, OH; Ursula A. Matulonis, Dana-Farber Cancer Institute; Michael J. Birrer, Massachusetts General Hospital, Boston; Rodrigo Ruiz-Soto, ImmunoGen, Waltham, MA; Jason A. Konner, Memorial Sloan Kettering Cancer Center, New York, NY; Raymond P. Perez, University of Kansas, Fairway, KS; and Todd M. Bauer, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.9538DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559878PMC
April 2017

Maximizing Synergistic Activity When Combining RNAi and Platinum-Based Anticancer Agents.

J Am Chem Soc 2017 03 16;139(8):3033-3044. Epub 2017 Feb 16.

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/jacs.6b12108DOI Listing
March 2017

Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.

Cancer 2016 Nov 15;122(21):3297-3306. Epub 2016 Jul 15.

Division of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30196DOI Listing
November 2016

Making a Difference: Distinguishing Two Primaries From Metastasis in Synchronous Tumors of the Ovary and Uterus.

J Natl Cancer Inst 2016 Jun 1;108(6):djv442. Epub 2016 Feb 1.

Department of Medicine, Massachusetts General Hospital, Boston, MA (DSD, MJB); Harvard Medical School, Boston, MA (DSD, MJB).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv442DOI Listing
June 2016

Targeting the Nuclear Import Receptor Kpnβ1 as an Anticancer Therapeutic.

Mol Cancer Ther 2016 04 1;15(4):560-73. Epub 2016 Feb 1.

Division of Medical Biochemistry, Department of Integrative Biomedical Sciences, Institute of Infectious Disease and Molecular Medicine, SAMRC/UCT Gynaecological Cancer Research Centre, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0052DOI Listing
April 2016

Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer.

N Engl J Med 2016 Feb;374(8):738-48

From the California Pacific-Palo Alto Medical Foundation, Sutter Cancer Research Institute, San Francisco (J.K.C.); NRG Oncology-Gynecologic Oncology Group Statistics and Data Center, Roswell Park Cancer Institute, Buffalo, NY (M.F.B., H.H.); Massachusetts General Hospital, Boston (R.T.P., M.J.B.); University of Oklahoma, Oklahoma City (J.L.W.); Women and Infants Hospital, Providence, RI (P.A.D.S.); University of Pennsylvania (S.C.R.) and Fox Chase Cancer Center (L.P.M.) - both in Philadelphia; University of Colorado Cancer Center, Aurora (S.A.D.); University of Alabama at Birmingham, Birmingham (W.K.H.); James Cancer Center, Ohio State University, Columbus (D.M.O.); Minnesota Oncology/Hematology-Oncology Service, Edina (M.P.B.); Indiana University School of Medicine, Carmel (H.M.); and University of Arizona Cancer Center, Creighton University School of Medicine, and St. Joseph's Hospital and Medical Center (B.J.M.) - all in Phoenix.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081077PMC
http://dx.doi.org/10.1056/NEJMoa1505067DOI Listing
February 2016

Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer.

Authors:
Kelly L Bolton Jonathan Tyrer Honglin Song Susan J Ramus Maria Notaridou Chris Jones Tanya Sher Aleksandra Gentry-Maharaj Eva Wozniak Ya-Yu Tsai Joanne Weidhaas Daniel Paik David J Van Den Berg Daniel O Stram Celeste Leigh Pearce Anna H Wu Wendy Brewster Hoda Anton-Culver Argyrios Ziogas Steven A Narod Douglas A Levine Stanley B Kaye Robert Brown Jim Paul James Flanagan Weiva Sieh Valerie McGuire Alice S Whittemore Ian Campbell Martin E Gore Jolanta Lissowska Hanna P Yang Krzysztof Medrek Jacek Gronwald Jan Lubinski Anna Jakubowska Nhu D Le Linda S Cook Linda E Kelemen Angela Brooks-Wilson Leon F A G Massuger Lambertus A Kiemeney Katja K H Aben Anne M van Altena Richard Houlston Ian Tomlinson Rachel T Palmieri Patricia G Moorman Joellen Schildkraut Edwin S Iversen Catherine Phelan Robert A Vierkant Julie M Cunningham Ellen L Goode Brooke L Fridley Susan Kruger-Kjaer Jan Blaeker Estrid Hogdall Claus Hogdall Jenny Gross Beth Y Karlan Roberta B Ness Robert P Edwards Kunle Odunsi Kirsten B Moyisch Julie A Baker Francesmary Modugno Tuomas Heikkinenen Ralf Butzow Heli Nevanlinna Arto Leminen Natalia Bogdanova Natalia Antonenkova Thilo Doerk Peter Hillemanns Matthias Dürst Ingo Runnebaum Pamela J Thompson Michael E Carney Marc T Goodman Galina Lurie Shan Wang-Gohrke Rebecca Hein Jenny Chang-Claude Mary Anne Rossing Kara L Cushing-Haugen Jennifer Doherty Chu Chen Thorunn Rafnar Soren Besenbacher Patrick Sulem Kari Stefansson Michael J Birrer Kathryn L Terry Dena Hernandez Daniel W Cramer Ignace Vergote Frederic Amant Diether Lambrechts Evelyn Despierre Peter A Fasching Matthias W Beckmann Falk C Thiel Arif B Ekici Xiaoqing Chen Sharon E Johnatty Penelope M Webb Jonathan Beesley Stephen Chanock Montserrat Garcia-Closas Tom Sellers Douglas F Easton Andrew Berchuck Georgia Chenevix-Trench Paul D P Pharoah Simon A Gayther

Nat Genet 2016 Jan;48(1):101

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng0116-101bDOI Listing
January 2016

Sustained, low-dose intraperitoneal cisplatin improves treatment outcome in ovarian cancer mouse models.

J Control Release 2015 Dec 5;220(Pt A):358-367. Epub 2015 Nov 5.

David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Materials Science, Massachusetts Institute of Technology, Cambridge, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jconrel.2015.11.001DOI Listing
December 2015

Ovarian cancer: targeting the untargetable.

Authors:
Michael J Birrer

Am Soc Clin Oncol Educ Book 2014 :13-5

From the Harvard Medical School, Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2014.34.13DOI Listing
November 2015

AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer.

Proc Natl Acad Sci U S A 2015 Aug 27;112(32):E4418-27. Epub 2015 Jul 27.

Pediatric Surgical Research Laboratories, Massachusetts General Hospital, Department of Surgery, Harvard Medical School, Boston, MA 02114;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1510604112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538667PMC
August 2015

Spleen Tyrosine Kinase Confers Paclitaxel Resistance in Ovarian Cancer.

Cancer Cell 2015 Jul;28(1):7-9

Center for Cancer Research, The Gillette Center for Gynecologic Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2015.06.008DOI Listing
July 2015

Advances in the management of recurrent endometrial cancer.

Am J Clin Oncol 2015 Apr;38(2):206-12

Departments of *Obstetrics-Gynecology †Medicine, Gillette Center for Gynecologic Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e31829a2974DOI Listing
April 2015

Translational impact of nanoparticle-drug conjugate CRLX101 with or without bevacizumab in advanced ovarian cancer.

Clin Cancer Res 2015 Feb 18;21(4):808-18. Epub 2014 Dec 18.

Biological Sciences Platform, Sunnybrook Research Institute, Toronto, Ontario, Canada. Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2810DOI Listing
February 2015

Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential.

Nat Commun 2014 Oct 3;5:5092. Epub 2014 Oct 3.

1] Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA [2] The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms6092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185407PMC
October 2014

Deep, noninvasive imaging and surgical guidance of submillimeter tumors using targeted M13-stabilized single-walled carbon nanotubes.

Proc Natl Acad Sci U S A 2014 Sep 11;111(38):13948-53. Epub 2014 Sep 11.

Koch Institute for Integrative Cancer Research, Departments of Materials Science and Engineering, Biological Engineering,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1400821111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183329PMC
September 2014

Advances in the diagnosis and treatment of uterine sarcomas.

Discov Med 2014 Jun;17(96):339-45

Gillette Center of Gynecologic Oncology, Massachusetts General, Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
June 2014

Better therapeutic trials in ovarian cancer.

J Natl Cancer Inst 2014 Apr 13;106(4):dju029. Epub 2014 Mar 13.

Affiliations of authors: University of Arizona Cancer Center, Tucson, AZ (MAB); Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, BC, Canada (CBG); Molecular Signalling Section, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD (ECK); Director, Policy and Advocacy, Prevent Cancer Foundation, Alexandria, VA (KOK); Pathology and Laboratory Medicine (DH) and Department of Medical Oncology (KDS), University of British Columbia, Vancouver, BC, Canada (DH); Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY (CA); Department of Medicine, Harvard Medical School, Massachusetts General Hospital, Boston, MA (MJB); CR UK/UCL Cancer Trials Centre, University College London Cancer Institute, London, UK (JAL); Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada (AMO).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982885PMC
April 2014

Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples.

J Natl Cancer Inst 2014 Apr 3;106(5). Epub 2014 Apr 3.

Affiliations of authors: Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA (MR, ACC, LT, FM, CH, GP); Department of Biostatistics, Harvard School of Public Health, Boston, MA (MR, ACC, LT, FM, CH, GP); Center for Cancer Research (WW, S-hK, MB) and Department of Pathology (EO), Massachusetts General Hospital, Boston, MA; City University of New York School of Public Health, Hunter College, New York, NY (LW); Sung-hoon Kim, Yonsei University College of Medicine, Seoul, Korea (S-HK).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580556PMC
April 2014

Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer.

Carcinogenesis 2014 Mar 29;35(3):546-53. Epub 2013 Oct 29.

Vincent Center for Reproductive Biology, Department of Obstetrics, Gynecology, and Reproductive Biology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgt357DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941742PMC
March 2014

p21-activated kinase 3 (PAK3) is an AP-1 regulated gene contributing to actin organisation and migration of transformed fibroblasts.

PLoS One 2013 20;8(6):e66892. Epub 2013 Jun 20.

Division of Medical Biochemistry, Faculty of Health Sciences, University of Cape Town, Institute of Infectious Disease and Molecular Medicine, Cape Town, South Africa.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0066892PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688571PMC
January 2014

Ascites analysis by a microfluidic chip allows tumor-cell profiling.

Proc Natl Acad Sci U S A 2013 Dec 2;110(51):E4978-86. Epub 2013 Dec 2.

Center for Systems Biology, Massachusetts General Hospital, Boston, MA 02114.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1315370110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870756PMC
December 2013

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.

Authors:
Jennifer Permuth-Wey Kate Lawrenson Howard C Shen Aneliya Velkova Jonathan P Tyrer Zhihua Chen Hui-Yi Lin Y Ann Chen Ya-Yu Tsai Xiaotao Qu Susan J Ramus Rod Karevan Janet Lee Nathan Lee Melissa C Larson Katja K Aben Hoda Anton-Culver Natalia Antonenkova Antonis C Antoniou Sebastian M Armasu François Bacot Laura Baglietto Elisa V Bandera Jill Barnholtz-Sloan Matthias W Beckmann Michael J Birrer Greg Bloom Natalia Bogdanova Louise A Brinton Angela Brooks-Wilson Robert Brown Ralf Butzow Qiuyin Cai Ian Campbell Jenny Chang-Claude Stephen Chanock Georgia Chenevix-Trench Jin Q Cheng Mine S Cicek Gerhard A Coetzee Linda S Cook Fergus J Couch Daniel W Cramer Julie M Cunningham Agnieszka Dansonka-Mieszkowska Evelyn Despierre Jennifer A Doherty Thilo Dörk Andreas du Bois Matthias Dürst Douglas F Easton Diana Eccles Robert Edwards Arif B Ekici Peter A Fasching David A Fenstermacher James M Flanagan Montserrat Garcia-Closas Aleksandra Gentry-Maharaj Graham G Giles Rosalind M Glasspool Jesus Gonzalez-Bosquet Marc T Goodman Martin Gore Bohdan Górski Jacek Gronwald Per Hall Mari K Halle Philipp Harter Florian Heitz Peter Hillemanns Maureen Hoatlin Claus K Høgdall Estrid Høgdall Satoyo Hosono Anna Jakubowska Allan Jensen Heather Jim Kimberly R Kalli Beth Y Karlan Stanley B Kaye Linda E Kelemen Lambertus A Kiemeney Fumitaka Kikkawa Gottfried E Konecny Camilla Krakstad Susanne Krüger Kjaer Jolanta Kupryjanczyk Diether Lambrechts Sandrina Lambrechts Johnathan M Lancaster Nhu D Le Arto Leminen Douglas A Levine Dong Liang Boon Kiong Lim Jie Lin Jolanta Lissowska Karen H Lu Jan Lubiński Galina Lurie Leon F A G Massuger Keitaro Matsuo Valerie McGuire John R McLaughlin Usha Menon Francesmary Modugno Kirsten B Moysich Toru Nakanishi Steven A Narod Lotte Nedergaard Roberta B Ness Heli Nevanlinna Stefan Nickels Houtan Noushmehr Kunle Odunsi Sara H Olson Irene Orlow James Paul Celeste L Pearce Tanja Pejovic Liisa M Pelttari Malcolm C Pike Elizabeth M Poole Paola Raska Stefan P Renner Harvey A Risch Lorna Rodriguez-Rodriguez Mary Anne Rossing Anja Rudolph Ingo B Runnebaum Iwona K Rzepecka Helga B Salvesen Ira Schwaab Gianluca Severi Viji Shridhar Xiao-Ou Shu Yurii B Shvetsov Weiva Sieh Honglin Song Melissa C Southey Beata Spiewankiewicz Daniel Stram Rebecca Sutphen Soo-Hwang Teo Kathryn L Terry Daniel C Tessier Pamela J Thompson Shelley S Tworoger Anne M van Altena Ignace Vergote Robert A Vierkant Daniel Vincent Allison F Vitonis Shan Wang-Gohrke Rachel Palmieri Weber Nicolas Wentzensen Alice S Whittemore Elisabeth Wik Lynne R Wilkens Boris Winterhoff Yin Ling Woo Anna H Wu Yong-Bing Xiang Hannah P Yang Wei Zheng Argyrios Ziogas Famida Zulkifli Catherine M Phelan Edwin Iversen Joellen M Schildkraut Andrew Berchuck Brooke L Fridley Ellen L Goode Paul D P Pharoah Alvaro N A Monteiro Thomas A Sellers Simon A Gayther

Nat Commun 2013 ;4:1627

Department of Cancer Epidemiology, Division of Population Sciences, Moffitt Cancer Center, Tampa, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms2613DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709460PMC
October 2013

Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting: taking endometrial cancer trials into the translational era.

Int J Gynecol Cancer 2013 Oct;23(8):1528-34

*Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands; †Institute of Cancer Sciences, University of Manchester, United Kingdom; ‡Division of Hematology and Oncology, Harvard Medical School and Massachusetts General Hospital, Boston, MA; §Division of Gynaecology, European Institute of Oncology, Milan, Italy; ∥Department of Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center, Houston, TX; ¶Department of Clinical Oncology, Barts Health NHS Trust, London, United Kingdom; #Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY; **Department of Gynaecology, Newcastle University and Northern Institute for Cancer Research, Newcastle upon Tyne, United Kingdom; ††Department of Obstetrics and Gynecology, College of Medicine, Ohio State University, Columbus, OH; ‡‡Department of Gynaecologic Oncology, Royal Women's Hospital, and Melbourne University Dept of Obstetrics and Gynaecology, Australia; §§Department of Obstetrics and Gynecology, Haukeland University Hospital; and Department of Clinical Medicine, University of Bergen, Norway; and ∥∥Department of Radiation Oncology, Sunnybrook Cancer Center, Toronto, Canada.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0b013e3182a26edbDOI Listing
October 2013

Clear cell cancer of the ovary.

Curr Opin Oncol 2013 Sep;25(5):553-7

Division of Hematology Oncology, Massachusetts General Hospital, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e328363e0c7DOI Listing
September 2013

Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer.

Int J Gynecol Cancer 2013 Sep;23(7):1219-25

Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e31829f17c9DOI Listing
September 2013

TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment.

Cancer Res 2013 Aug 3;73(16):5016-28. Epub 2013 Jul 3.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-0023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745588PMC
August 2013

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.

Authors:
Paul D P Pharoah Ya-Yu Tsai Susan J Ramus Catherine M Phelan Ellen L Goode Kate Lawrenson Melissa Buckley Brooke L Fridley Jonathan P Tyrer Howard Shen Rachel Weber Rod Karevan Melissa C Larson Honglin Song Daniel C Tessier François Bacot Daniel Vincent Julie M Cunningham Joe Dennis Ed Dicks Katja K Aben Hoda Anton-Culver Natalia Antonenkova Sebastian M Armasu Laura Baglietto Elisa V Bandera Matthias W Beckmann Michael J Birrer Greg Bloom Natalia Bogdanova James D Brenton Louise A Brinton Angela Brooks-Wilson Robert Brown Ralf Butzow Ian Campbell Michael E Carney Renato S Carvalho Jenny Chang-Claude Y Anne Chen Zhihua Chen Wong-Ho Chow Mine S Cicek Gerhard Coetzee Linda S Cook Daniel W Cramer Cezary Cybulski Agnieszka Dansonka-Mieszkowska Evelyn Despierre Jennifer A Doherty Thilo Dörk Andreas du Bois Matthias Dürst Diana Eccles Robert Edwards Arif B Ekici Peter A Fasching David Fenstermacher James Flanagan Yu-Tang Gao Montserrat Garcia-Closas Aleksandra Gentry-Maharaj Graham Giles Anxhela Gjyshi Martin Gore Jacek Gronwald Qi Guo Mari K Halle Philipp Harter Alexander Hein Florian Heitz Peter Hillemanns Maureen Hoatlin Estrid Høgdall Claus K Høgdall Satoyo Hosono Anna Jakubowska Allan Jensen Kimberly R Kalli Beth Y Karlan Linda E Kelemen Lambertus A Kiemeney Susanne Krüger Kjaer Gottfried E Konecny Camilla Krakstad Jolanta Kupryjanczyk Diether Lambrechts Sandrina Lambrechts Nhu D Le Nathan Lee Janet Lee Arto Leminen Boon Kiong Lim Jolanta Lissowska Jan Lubiński Lene Lundvall Galina Lurie Leon F A G Massuger Keitaro Matsuo Valerie McGuire John R McLaughlin Usha Menon Francesmary Modugno Kirsten B Moysich Toru Nakanishi Steven A Narod Roberta B Ness Heli Nevanlinna Stefan Nickels Houtan Noushmehr Kunle Odunsi Sara Olson Irene Orlow James Paul Tanja Pejovic Liisa M Pelttari Jenny Permuth-Wey Malcolm C Pike Elizabeth M Poole Xiaotao Qu Harvey A Risch Lorna Rodriguez-Rodriguez Mary Anne Rossing Anja Rudolph Ingo Runnebaum Iwona K Rzepecka Helga B Salvesen Ira Schwaab Gianluca Severi Hui Shen Vijayalakshmi Shridhar Xiao-Ou Shu Weiva Sieh Melissa C Southey Paul Spellman Kazuo Tajima Soo-Hwang Teo Kathryn L Terry Pamela J Thompson Agnieszka Timorek Shelley S Tworoger Anne M van Altena David van den Berg Ignace Vergote Robert A Vierkant Allison F Vitonis Shan Wang-Gohrke Nicolas Wentzensen Alice S Whittemore Elisabeth Wik Boris Winterhoff Yin Ling Woo Anna H Wu Hannah P Yang Wei Zheng Argyrios Ziogas Famida Zulkifli Marc T Goodman Per Hall Douglas F Easton Celeste L Pearce Andrew Berchuck Georgia Chenevix-Trench Edwin Iversen Alvaro N A Monteiro Simon A Gayther Joellen M Schildkraut Thomas A Sellers

Nat Genet 2013 Apr;45(4):362-70, 370e1-2

The Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.2564DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693183PMC
April 2013

SUZ12 promotes human epithelial ovarian cancer by suppressing apoptosis via silencing HRK.

Mol Cancer Res 2012 Nov 10;10(11):1462-72. Epub 2012 Sep 10.

Gene Expression and Regulation Program, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-12-0335DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501543PMC
November 2012

RASSF1A and the Taxol Response in Ovarian Cancer.

Mol Biol Int 2012 3;2012:263267. Epub 2012 Apr 3.

J.G. Brown Cancer Center, University of Louisville, 417 CTR Building, 505 S. Hancock Street, Louisville, KY 40202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/263267DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324163PMC
August 2012

Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer.

PLoS One 2012 17;7(1):e29079. Epub 2012 Jan 17.

Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0029079PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260150PMC
June 2012

ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approaches.

Cancer Prev Res (Phila) 2012 Mar 5;5(3):484-91. Epub 2011 Dec 5.

Women's Cancer Program and Epigenetics and Progenitor Cell Keystone Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://cancerpreventionresearch.aacrjournals.org/cgi/doi/10.
Publisher Site
http://dx.doi.org/10.1158/1940-6207.CAPR-11-0414DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294119PMC
March 2012

The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.

Authors:
Paul D P Pharoah Rachel T Palmieri Susan J Ramus Simon A Gayther Irene L Andrulis Hoda Anton-Culver Natalia Antonenkova Antonis C Antoniou David Goldgar Mary S Beattie Matthias W Beckmann Michael J Birrer Natalia Bogdanova Kelly L Bolton Wendy Brewster Angela Brooks-Wilson Robert Brown Ralf Butzow Trinidad Caldes Maria Adelaide Caligo Ian Campbell Jenny Chang-Claude Y Ann Chen Linda S Cook Fergus J Couch Daniel W Cramer Julie M Cunningham Evelyn Despierre Jennifer A Doherty Thilo Dörk Matthias Dürst Diana M Eccles Arif B Ekici Douglas Easton Peter A Fasching Anna de Fazio David A Fenstermacher James M Flanagan Brooke L Fridley Eitan Friedman Bo Gao Olga Sinilnikova Aleksandra Gentry-Maharaj Andrew K Godwin Ellen L Goode Marc T Goodman Jenny Gross Thomas V O Hansen Paul Harnett Matti Rookus Tuomas Heikkinen Rebecca Hein Claus Høgdall Estrid Høgdall Edwin S Iversen Anna Jakubowska Sharon E Johnatty Beth Y Karlan Noah D Kauff Stanley B Kaye Georgia Chenevix-Trench Linda E Kelemen Lambertus A Kiemeney Susanne Krüger Kjaer Diether Lambrechts James P Lapolla Conxi Lázaro Nhu D Le Arto Leminen Karin Leunen Douglas A Levine Yi Lu Lene Lundvall Stuart Macgregor Tamara Marees Leon F Massuger John R McLaughlin Usha Menon Marco Montagna Kirsten B Moysich Steven A Narod Katherine L Nathanson Lotte Nedergaard Roberta B Ness Heli Nevanlinna Stefan Nickels Ana Osorio Jim Paul Celeste Leigh Pearce Catherine M Phelan Malcolm C Pike Paolo Radice Mary Anne Rossing Joellen M Schildkraut Thomas A Sellers Christian F Singer Honglin Song Daniel O Stram Rebecca Sutphen Annika Lindblom Kathryn L Terry Ya-Yu Tsai Anne M van Altena Ignace Vergote Robert A Vierkant Allison F Vitonis Christine Walsh Shan Wang-Gohrke Barbara Wappenschmidt Anna H Wu Argyrios Ziogas Andrew Berchuck Harvey A Risch

Clin Cancer Res 2011 Jun 8;17(11):3742-50. Epub 2011 Mar 8.

Department of Oncology, University of Cambridge, Cambridge, United Kingdom.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/17/11/3742.ful
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-10-3405DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107901PMC
June 2011

The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer.

Am J Surg Pathol 2011 Jun;35(6):904-12

Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e318212ae22DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095702PMC
June 2011

Nuclear P27 expression in benign, borderline (LMP) and invasive tumors of the ovary and its association with prognosis: a gynecologic oncology group study.

Gynecol Oncol 2011 May 18;121(2):395-401. Epub 2011 Feb 18.

Division of Gynecologic Oncology, Department of Obstetrics/Gynecology, Walter Reed Army Medical Center, Washington, DC 20307, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009082581000849
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2010.11.023DOI Listing
May 2011

Inhibition of AP-1 suppresses cervical cancer cell proliferation and is associated with p21 expression.

Biol Chem 2011 May 22;392(5):439-48. Epub 2011 Mar 22.

Division of Medical Biochemistry, University of Cape Town, Institute of Infectious Disease and Molecular Medicine, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/BC.2011.036DOI Listing
May 2011